Man Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Buy |
274,684
+88,588
| +48% | +$100K | ﹤0.01% | 1725 |
|
|
2025
Q1 | $272K | Buy |
+186,096
| New | +$272K | ﹤0.01% | 1733 |
|
|
2024
Q1 | – | Sell |
-13,800
| Closed | -$44.3K | – | 1969 |
|
|
2023
Q4 | $44.3K | Buy |
+13,800
| New | +$44.3K | ﹤0.01% | 1884 |
|
|
2023
Q3 | – | Sell |
-220,307
| Closed | -$1.09M | – | 1668 |
|
|
2023
Q2 | $1.09M | Buy |
+220,307
| New | +$1.09M | ﹤0.01% | 1340 |
|
|
2022
Q1 | – | Sell |
-48,576
| Closed | -$725K | – | 2018 |
|
|
2021
Q4 | $725K | Sell |
48,576
-3,996
| -8% | -$59.6K | ﹤0.01% | 1412 |
|
|
2021
Q3 | $1.35M | Buy |
+52,572
| New | +$1.35M | ﹤0.01% | 1272 |
|
|
2021
Q2 | – | Sell |
-54,202
| Closed | -$1.91M | – | 1861 |
|
|
2021
Q1 | $1.91M | Sell |
54,202
-49,404
| -48% | -$1.74M | 0.01% | 1120 |
|
|
2020
Q4 | $2.62M | Sell |
103,606
-17,776
| -15% | -$449K | 0.01% | 1099 |
|
|
2020
Q3 | $4.58M | Buy |
121,382
+6,835
| +6% | +$258K | 0.02% | 859 |
|
|
2020
Q2 | $4.91M | Sell |
114,547
-25,942
| -18% | -$1.11M | 0.02% | 667 |
|
|
2020
Q1 | $2.73M | Buy |
140,489
+89,722
| +177% | +$1.74M | 0.02% | 744 |
|
|
2019
Q4 | $1.32M | Buy |
+50,767
| New | +$1.32M | ﹤0.01% | 1433 |
|
|
2019
Q3 | – | Sell |
-15,181
| Closed | -$408K | – | 1760 |
|
|
2019
Q2 | $408K | Sell |
15,181
-18,619
| -55% | -$500K | ﹤0.01% | 1699 |
|
|
2019
Q1 | $977K | Buy |
+33,800
| New | +$977K | ﹤0.01% | 1576 |
|